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Introduction
Patients with systemic lupus erythematous (SLE) often
develop neuropsychiatric disease. Central nervous sys-
tem (CNS) manifestations of SLE occur in about half of
all patients, and psychiatric presentations are seen with
a prevalence of 35% to 60% in this group. Electroconvul-
sive therapy (ECT) also known as electroshock therapy
is a psychiatric treatment in which electricity/electric
shock is used to induce convulsions. It is used to treat
psychiatric diseases such as depression, schizophrenia,
mania or catatonia that do not respond to conventional
treatment.
Objectives
To describe a patient with refractory neuropsychiatric
lupus who responded to electroconvulsive therapy.
Methods
Case Report: A 25-year-old woman with a 13-year
history of SLE characterized by arthritis, thrombocyto-
penia, positive antinuclear antibody in a titer of 1:2,560
(speckled pattern), and the presence of antibodies to Sm
and antiribosomal P protein autoantibodies was
admitted to University Hospital with an organic psycho-
sis. She was treated with corticosteroids, cyclophospha-
mide and azathioprine and went into remission. When
she was 18 yo, she had a relapse (depression) and was
treated with methyl prednisolone (MP) pulse therapy
(PT) and cyclophosphamide. After 6 months, she had
another episode of psychosis (echolalia, repetitive hands
movements, extreme anxiety and suicide tendency)
which did not respond to MP PT, Cyclophosphamide,
Rituximab and Intravenous Immunoglobulin. Magnetic
Resonance of the brain was normal, CSF results were
inconclusive, antiphospholipid, anti dsDNA and anti Sm
antibodies were all negative. She had various episodes of
aggressiveness, agitation, insomnia, nightmares, halluci-
nations, difficulty in concentrating, repetitive move-
ments of both upper and lower limbs, phases of
catatonia and suicidal tendencies. Psychotropic agents,
antidepressants and anxiolytics were used with little
response clinically. After 18 months of immunosuppres-
sive and anti-psychotics treatment without improve-
ment, an ECT trial was begun. After 4 sessions of ECT,
the patient had a remarkable improvement of her psy-
chiatric symptoms, she was able to sleep and respond
normally to her surroundings. She had a total of 10
sessions of ECT.
Results
Psychosis is one of the severe neuropsychiatric manifes-
tations of LES. There are few studies about the use of
electroconvulsive therapy in the treatment of neuropsy-
chiatric lupus. Mon, L’Ecuyer et al (2012) reported the
use of ECT in the treatment of a child with catatonia
and neuropsychiatric lupus with similar good results.
Conclusion
The failure of antipsychotic and anticonvulsant medica-
tions, benzodiazepines, high-dose steroids, rituximab and
immunoglobulin in this patient dictated the need for
other treatment modalities. The decision to use ECT was
based on the success of this treatment for psychiatric
manifestations of systemic disorders. There are few
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